Dale R. Shepard

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Lawrence Fong, Andrew Hotson, John D. Powderly et al. · Cancer Discovery · 2019 · 339 citations · Full text

Medicine, Immunology, Oncology +17

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

Brian I. Rini, Tanya B. Dorff, Paul Elson et al. · The Lancet Oncology · 2016 · 254 citations · Full text

Medicine, Nephrology, Oncology +14

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

David M. Peereboom, Dale R. Shepard, Manmeet S. Ahluwalia et al. · Journal of Neuro-Oncology · 2009 · 199 citations

Medicine, Oncology, Pharmacology +14

Intratumoral Injection of <i>Clostridium novyi</i> -NT Spores in Patients with Treatment-refractory Advanced Solid Tumors

Filip Jankú, Halle Huihong Zhang, Abdulmohammad Pezeshki et al. · Clinical Cancer Research · 2020 · 155 citations · Full text

Pharmacy, Oncology, Toxicology +14

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016

Noam VanderWalde, Reshma Jagsi, Efrat Dotan et al. · Journal of the National Comprehensive Cancer Network · 2016 · 122 citations · Full text

Medicine, Oncology, Radiation Oncology +15